Xenon Pharmaceuticals, Inc. (XENE)
37.58
-0.44
(-1.16%)
USD |
NASDAQ |
Oct 05, 16:00
37.77
+0.19
(+0.51%)
After-Hours: 20:00
Xenon Pharmaceuticals EPS Diluted (Quarterly) : -1.112 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.112 |
| March 31, 2026 | -1.171 |
| December 31, 2025 | -1.314 |
| September 30, 2025 | -1.147 |
| June 30, 2025 | -1.073 |
| March 31, 2025 | -0.8266 |
| December 31, 2024 | -0.838 |
| September 30, 2024 | -0.8058 |
| June 30, 2024 | -0.7458 |
| March 31, 2024 | -0.6177 |
| December 31, 2023 | -0.6395 |
| September 30, 2023 | -0.7342 |
| June 30, 2023 | -0.7206 |
| March 31, 2023 | -0.6349 |
| December 31, 2022 | -0.5695 |
| September 30, 2022 | -0.5675 |
| June 30, 2022 | -0.5545 |
| March 31, 2022 | -0.3531 |
| December 31, 2021 | -0.4857 |
| September 30, 2021 | -0.3661 |
| June 30, 2021 | -0.5008 |
| March 31, 2021 | -0.4166 |
| December 31, 2020 | -0.342 |
| September 30, 2020 | -0.2459 |
| June 30, 2020 | -0.0049 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2188 |
| December 31, 2019 | -0.4151 |
| September 30, 2019 | -0.3309 |
| June 30, 2019 | -0.3737 |
| March 31, 2019 | -0.4237 |
| December 31, 2018 | -0.3178 |
| September 30, 2018 | -0.6285 |
| June 30, 2018 | -0.45 |
| March 31, 2018 | -0.209 |
| December 31, 2017 | -0.45 |
| September 30, 2017 | -0.43 |
| June 30, 2017 | -0.41 |
| March 31, 2017 | -0.43 |
| December 31, 2016 | -0.3348 |
| September 30, 2016 | -0.51 |
| June 30, 2016 | -0.42 |
| March 31, 2016 | -0.23 |
| December 31, 2015 | -0.27 |
| September 30, 2015 | -0.27 |
| June 30, 2015 | -0.07 |
| March 31, 2015 | -0.30 |
| December 31, 2014 | 0.13 |
| September 30, 2014 | 1.69 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Psyence Biomedical Ltd. | -3.178 |
| Aurinia Pharmaceuticals, Inc. | 0.2802 |
| enGene Therapeutics, Inc. | -0.4661 |
| Medicus Pharma Ltd. | -0.1524 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -110.74M |
| Total Expenses (Quarterly) | 110.74M |
| Enterprise Value | 2.754B |
| Earnings Yield | -12.62% |
| Normalized Earnings Yield | -12.62 |